Director, Site & Patient Diversity
Director, Site & Patient Diversity
Angel Akinbinu is the Director of Site and Patient Diversity at Syneos Health, where she leads the strategy development and implementation of diversity, equity, and inclusion in clinical trials.
Prior to joining Syneos, she worked in both CROs and large pharma, creating and executing patient recruitment and retention strategies, later transitioning to work focused on increasing representation and access for underserved and underrepresented patient populations in clinical trials. She has worked in multiple therapeutic areas including oncology, infectious disease and vaccines, neuroscience, and immunology.
Angel earned her Bachelor of Arts degree from Hampton University and Master of Arts in Criminology & Criminal Justice from the University of Maryland. She lives in the Raleigh, NC area with her husband and two children.
Todd Albin, MBA
Cedar Health Research
Todd Albin launched Cedar Health Research in 2019 following more than two decades of experience as leader in the clinical research industry. He is an expert in the areas of clinical research site operations and patient recruitment solutions.
Whitley Albright, MSN
Site and Patient Focused Innovation Project Manager
Whitley Albright is a Site and Patient Focused Innovation Project Manager at Sanofi who is passionate about improving the site and patient experience. In this role, she strives to ensure Sanofi’s innovation strategy consistently considers and prioritizes functionality and utility of innovative solutions for our site teams and patients. Having previously worked as a Clinical Research Nurse Coordinator (CRC), she has a great appreciation for the value of insights and experiences of sites and the challenges that only they experience.
Whitley has her Master of Science in Nursing, with a focus on Clinical Trial Management, from Kansas University with experience as a Clinical Project Leader, Site Partnership Manager, CRA and Pediatric CRC. When not contemplating innovation, Whitley can be found cooking, baking, reading, gardening, hiking and adventuring outdoors with her husband and 2 little girls!
Founder & CEO
Drawing on his engineering background, and inspired by his work in clinical research, Rick Arlow built the first version of the Complion software platform. In close collaboration with leading medical centers, Complion’s industry-leading workflow and document management software was born. Since then, he has built a world-class team experienced in clinical research. He is a frequent lecturer for several professional research organizations including ACRP, MAGI and SCRS. Previously, Rick was involved with a biotech business resulting in several patents and was recognized in Business Week’s “Top 25 Under 25 Entrepreneurs”.
Deena Bernstein, MHS
Vice President Customer Success
Deena Bernstein has deep expertise in healthcare leadership and the clinical research industry. Her career spans over twenty years in clinical research site development, operations and digital technology for the clinical research industry. Deena is a passionate leader with an entrepreneurial spirit that cares deeply about improving the clinical trial experience and process for study participants. She thrives on innovation and is the VP of Customer Success at Datacubed Health where she is focused on delighting customers, participant engagement & retention, decentralized clinical trial models and clinical research as a care option. She looks as her role as the Ambassador to Happiness Deena’s has held leadership and executive roles at large Healthcare organizations, IQVIA (Fortune 500), IRO’s and Datacubed Health where she’s expanded her horizons by entering the mHealth space which uses behavioral science and Saas Technology to improve patient compliance and retention to increase data quality in clinical trials.
Michele Cameron, MBA, BSN, RN, CCRC
Director of Clinical Research
Clearwater Cardiovascular Consultants
Michele Cameron is the Director of Clinical Research for Clearwater Cardiovascular Consultants, a large independent cardiology practice located in Clearwater, Florida. The practice has supported a Clinical Research Dept. for over 30 years. Michele joined the Dept. in 2005 and has since grown and cultivated a highly successful practice-based site. The Site conducts 30-35 cardiovascular related drug and device studies in both the clinic and hospital settings. All 23 practice physicians participate in clinical research and are CITI trained investigators. The Clinical Research Dept has 14 dedicated clinical research staff. Subjects are recruited from the practice database of over 140,000 patients. The practice recently added an Ambulatory Surgery Center where the Research Team looks forward to enrolling subjects. Michele brings a diverse background to her position with experience in clinical research at Johnson and Johnson, GE Medical, as a critical care nurse and as the owner of a seafood company. Michele currently serves as the SCRS Membership Committee Chair and in 2022, was awarded the SCRS Christine K. Pierre Site Impact Award. She is grateful for and credits much of her success to the mentorship she has received from SCRS over the last 10 plus years.
Business Development Manager
Mia is a Senior Product Manager at Teckro, a company with the mission to modernize and simplify clinical research. She is passionate about helping the healthcare providers achieve better clinical outcome and eventually making an impact to patients. Over the past 10 years, she’s been working in the healthcare industry and discovering innovative solutions together with people from diverse backgrounds.
April Coburn, BA, MLA
Associate Director, Therapeutic Area – Site Activation Liaison
April has been in clinical research since 2006. From Start-Up to Medical Writing, she has led change in our industry over the years. She now acts as a Site Activation Liaison within ICON, developing relationships globally with institutions.
Paul is an associate product manager with extensive experience in clinical trials, healthcare and patient advocacy. Currently working on building exciting products at StudyKIK with an amazing team and enjoying every moment. This has included owning our own creative and technical direction to make sure we are able to support business and product objectives at all levels.
Anthony Todd Everhart, MD, FACP
Clinical Vice President, Internal Medicine
Dr. Everhart is an innovator, educator, and leader in the pharmaceutical and biotechnology industries with over 25 years of experience in the practice of medicine and over 14 years of experience in clinical research. Prior to joining Signant Health as Clinical Vice President of Internal Medicine, Dr. Everhart held positions of Vice President, Medical Affairs and Vice President, Medical Informatics at Chiltern and Covance, and has consulted independently in the areas of medical monitoring, medical data review, data analytics, and physician adoption of technology. Board-certified in Internal Medicine and a Fellow of the American College of Physicians, he has worked in all phases of clinical development in numerous therapeutic areas including allergy & immunology, cardiovascular, dermatology, hematology & oncology, infections disease & HIV, neurology, ophthalmology, psychiatry, respiratory, and rheumatology. Dr. Everhart is one of Signant Health’s experts in rater training, blinded data analytics, placebo response mitigation, and decentralized trials.
Roman Fishchuk, MD, MSc
CEO, Clinical Trials Unit
Central City Clinical Hospital of Ivano-Frankivsk City Council
CEO of a clinical trials unit that was founded from scratch in 2017 at a state hospital in Ivano-Frankivsk, Ukraine and now developed into an organization with 15-20 multi-specialty trials running simultaneously with a potential to grow. One of the founders and current Board member of the Ukrainian Association for Clinical Research. Adept ENT doctor and principal investigator in otolaryngology with ability to work in a multidisciplinary team, experience in delivering patient care in both public and private settings with the use of the latest industry equipment and technology, as well as establishing own private practice. Proactive and dedicated to seeking opportunities for cooperation with international specialists. Strong knowledge of Ukrainian medical policy landscape through working with the Ministry of Health of Ukraine on reforming healthcare services. Proven track record of planning and executing projects in medical sphere.
Nicholas Focil, MBA, MS
Fomat Medical Research
Nicholas Focil is the founder and CEO of FOMAT Medical Research– an Integrated Research Organization with over 10 years of experience conducting clinical research in a wide variety of therapeutic areas. As CEO of a medical research company, Nicholas aims to diversify clinical trials, bring innovative healthcare to underrepresented populations, and ensure that high-quality data is contributed to the scientific community to create better treatments. In recognition of the company’s innovative advancements in COVID-19 research, FOMAT was even named 2020s Innovative Business of the Year by Oxnard, California’s Chamber of Commerce. Nicholas is currently chairman and co-founder of Febo, an app chosen by the Northern California MIT Healthcare Association as a top 100 healthcare startup (and is part of the Plug and Play ecosystem). Nicholas also became an Execute Board Member of hyperCORE International, the second-largest research organization in the world. This membership is in addition to previous ones where the was once part of the Innovation Steering Committee of ACRP and Forbes Los Angeles Business Council back in 2018. Moreover, as early as 2008, Nicholas has done numerous publications and speaking engagements within the scientific and business fields and is part of his Alma Maters top 40 under 40.
Diana Foster, PhD
Dr. Diana L. Foster currently serves as the Chief Executive Officer for Total Diversity Clinical Trial Management. She has worked with Total Diversity since inception and has guided Total Diversity as it has become a full-service contract research organization.
Associate Director, Product Management
Lesley is currently the Associate Director of Product for IQVIA Technologies, Site and Planning Suite. She has over 15 years of industry experience with various perspectives, which she has gained from multiple roles throughout her career. Her passion for clinical research was ignited by her work as a research assistant and study coordinator, helping patients with cardiac and retinal disease, respectively. From there she moved on to project management for site facing technologies where she helped clients find, and effectively implement, the best solutions for their studies. She is now in a product management role where she is hyper focused on the voice of the customer, ensuring IQVIA’s technology solutions are being built, designed, enhanced, and implemented, based on consistent input and advice from Sites and Sponsors. She believes trust and transparency are at the core of success. Her goal for technology, is to play a better role in allowing sites and sponsors to have more trusting and transparent relationships.
Director of Cost Benchmarking and Site Contracts
Sharon has more than 30 years’ experience in site budgeting and site contracting. She currently leads the business operations of the GrantPlan family of products, as well as the services related to investigator contract and budget negotiation, investigator budget development, and fair market value reviews.
Rick Greenfield, BBA-IS
Founder & President
RealTime Software Solutions, LLC
Rick has 20+ years of experience in the Clinical Research industry. He was part owner & helped build one of the largest multi-specialty research sites in the US. His goal is to continue to build innovative systems for sites, Sponsor & CROs to contribute to operational excellence in clinical trials.
Consultant, Participant and Patient Advocate
LCH Research Consulting
Larissa Harrison is a Clinical Trial Operations and Strategy Consultant. She provides Consulting, Planning, and Implementation Services in the Healthcare Technology, Pharmaceutical, and Biotech space. With over 15 years of experience in the industry, Larissa knows what truly drives clinical trial innovation and successful patient engagement—and it’s not investing in the same, outdated “solutions” which have often put the onus on physicians and patients. It’s about combining technology, data, and novel design to bring efficient, person-centered, and inclusive clinical trials to community physicians and patients that truly address our greatest public health needs.
Larissa has served as the Head of Operations and Director of Site and Patient Networks for Avacare, an IQVIA company, and as Director of Site Development for one of the largest, global Site Management Organizations in the world. As an avid Patient Advocate in her home state of Arizona, Larissa works on behalf of those who have received a cancer diagnosis. She is passionate about connecting patients and families with resources that can help them take charge of their health.
Melissa Holbrook, MSN, BSN
Executive Vice President, Operations
Velocity Clinical Research
Melissa has over 30 years of clinical research industry experience where she has held positions in both Commercial as well as Academic Research Organizations. She has held positions at all levels including, CRC, Site Manager, CRA, Project Manager, head of risk based monitoring teams and Chief of Staff leading key strategic initiatives for a large global CRO. Regardless of her role, she has always gravitated back to site facing roles such as Head of the US Partner and Prime Site Program for Quintiles. She holds a master’s degree from Duke University and currently serves as the Executive Vice President of Operations at Velocity Clinical Research.
CEO / Co-Founder
Brian Horan brings over 25 years of experience in commercial and clinical trial pharmaceuticals, specializing in pharmacy and pharmacy benefit manager (PBM) networks. In 2012, he co-founded the pharmacy card concept for clinical supply in North America. Recently, Brian co-founded SupplyRx, the first cloud-based pharmacy card platform connecting sponsors, CROs, research sites, and patients for just-in-time commercial clinical trial supply. Leveraging technology and pharmacy networks, SupplyRx simplifies the clinical supply chain, reducing costs, increasing efficiency, and minimizing waste. The platform ensures a paperless environment and offers on-demand financial and patient transaction reporting by site and subject numbers.
Jennifer Hunter, CCRP, BAAS
Director of Research Operations
Mary Crowley Cancer Research
Jennifer Hunter joined Mary Crowley Cancer Research, an early-phase oncology clinical trial site network, in 2013 and currently serves as the Director of Research Operations. In this role, she oversees study development, budget and project management, regulatory affairs, trial management, medical records, quality assurance, and data management. Believing that people are any organization’s greatest asset, her core focus is empowering the team and developing new leaders. She values innovation, boldness, and solution-focused, strategic vision workshop sessions. Jenn and the MCCR team have conquered various system implementations, process improvements, and organizational restructuring. These opportunities have created a culture of continuous improvement with core values of quality, innovation, and collaboration.
Director, Site Relationship Management
Sean Jensen currently serves as Director of Site Relationship Management for Merck Research Laboratory’s Global Clinical Trial Organization (MRL-GCTO). He and his team are responsible for partnering with and supporting key strategic sites across the US and increasing site engagements. He aims to position the organization as partner of choice. Sean is a hands-on strategic leader with over 12 years’ experience in operations, partnerships, supply chain and finance across the biopharmaceutical and healthcare industries. Outside of work he enjoys reading, writing, and adventuring with his wife and two dogs.
Mia Li, MS
Senior Product Manager
Mia is a Senior Product Manager at Teckro, a company with the mission to modernize and simplify clinical research. She is passionate about helping the healthcare providers achieve better clinical outcome and eventually making an impact to patients. Over the past 10 years, she’s been working in the healthcare industry and discovering innovative solutions together with people from diverse backgrounds.
Conor Kane, MBA, B. Eng
Senior Director, Janssen Clinical Innovation
Within Janssen Clinical Innovation, Conor’s focus in on the discovery, development and deployment of innovative capabilities to create sustainable benefits for patients and sites. Prior to his current role, Conor was a Global Program Leader for Immunology Clinical Trials.
COO & Founder/CEO
Trialogic & SGM Alliance
|Garo Kiledjian is the COO for Trialogic and Founder/CEO of SGM Alliance. SGM Alliance is a nonprofit organization that focuses on education and advocacy for (SGM) Sexual and Gender Minorities in healthcare and the clinical research industry. He’s served in roles such as VP of Global Operations and Human Resources, as well as multilevel roles within administration, research, pharmacy, and finance. Garo has extensive experience in the LGBTQIA+ healthcare space and is an advocate for this community. He is currently on the executive committee for the National LGBTQ Task Force, a social justice group that focuses on legislative and policy changes from the grassroots level in DC. He is passionate about DEI and offers a unique perspective on how intersectionality of race and ethnicity overlap with gender and sexuality. Garo earned his Bachelor’s from UCLA and studied Leadership and Global Strategy at Woodbury’s Graduate School of Business.|
Associate Vice President, Client Engagement
As Associate Vice President, of Client Engagement, Kathy sets the strategy for all Greenphire client partnerships, from design and consulting services, process optimization, through governance and relationship management.
Henry Kravchenko is the founder and CEO of Clinical.ly, a technology company with the mission to provide clinical trials software that puts you in control. His goal is to work closely with the research community & incorporate customer feedback into everything Clinical.ly does. Henry aims to bring the latest advancements in intuitive, web-based technology to clinical research organizations. Clinical.ly’s technology enables its customers to better serve patients and sponsors.
Sr. Director Strategic Accounts
Alan Lane, Senior Director of Strategic Accounts at OneStudyTeam, works with biopharmaceutical sponsors to optimize and accelerate clinical trial enrollment across their trial sites. One of Alan’s current focuses is driving the use of diversity reporting tools to more easily identify causes of underrepresentation in trials, while taking steps to eliminate barriers to inclusion. Alan is a seasoned life sciences sales professional with 20+ years of delivering results for tier one and two global organizations requiring complex sales navigation.
Rochester Clinical Research / Atlas
Adam Larrabee has 15 years of dedicated site experience. He leads a team of 80 researchers and has experience with a multitude of site technologies – the good, the bad, and the ugly!
Karen McIntyre, MSc Clinical Trials
Vice President, Global Site Alliances
Karen’s current position within Parexel Launch Excellence Office as Vice President, Global Site Alliance provides a link as a site advocate.
Vice President, Decentralized Clinical Trials
Kelly McKee serves as vice president of Decentralized Clinical Trials (DCTs) in Patient Cloud at Medidata. She is responsible for creating new solutions to engage clinical trial patients pre-trial, in-trial, and post-trial, as well as developing patient and product communications around all Patient Cloud Products for decentralized and hybrid clinical trials. Kelly is a proven clinical trial leader and trailblazer in operationalizing global patient-focused solutions across organizations including innovations in clinical trial awareness, access, and improvements in patient experiences. Prior to Medidata, she spent over 20 years within clinical operations and patient recruitment at top-tier pharmaceutical companies including Sanofi, Merck, Eli Lilly and Co., and Vertex Pharmaceuticals. Kelly is passionate about celebrating the role that clinical trial participants bring in making new medicines and vaccines possible and was named one of Life Sci Voice’s Top Industry Leaders in 2022, PharmaVoice’s 100 Most Inspiring Leaders in 2020, Centerwatch’s Top 20 Innovators of 2018, and PharmaTimes’ Clinical Researcher of the Year, Clinical Research Teams, in 2012. She holds a bachelor’s degree in biology from Bryn Mawr College and a masters degree in clinical research administration from George Washington University.
Kathleen McNaughton, J.D., CHRC
Research Compliance Officer
Kathleen McNaughton, J.D., CHRC, is the Research Compliance Officer at Mayo Clinic. In this role she provides strategic guidance and oversight of the research compliance program, while also advocating for simplification which advances research and improves access to clinical trials.
With a life-long background dedicated to helping others and a keen eye for business, starting a career in the clinical space always interested Mohammad. As CEO and Founder of DM Clinical, Mohammad first set out to build an adept enterprise that not only was agile, but served a helpful niche in society.
His desire to ensure DM Clinical achieved the latter was exacerbated in 2008, when Millwala’s three-day-old nephew was stricken with illness and Mohammad was forced to watch as his newest family member’s life hung in the balance. Witnessing first-hand the real world impact of healthcare drove Millwala’s goals to new heights, and in his own words the life of DM Clinical “took on new meaning” after this experience. No longer was DM Clinical solely a business operating in an impact-driven space; DM Clinical was now a full-time large scale infrastructure dedicated to successfully helping individuals on a patient-by-patient basis. Mohammad keeps close to his heart the knowledge that DM Clinical serves the individual, and every recipient of the treatment DM Clinical helps provide is someone’s loved one in need of care. This drive has set DM Clinical apart from its competitors by utilizing successful business practices such as organization, collaboration, and flexibility to drive patient empowerment.
At his core, Millwala is a multifaceted, dynamic learner who above all values honesty and humility. Those close to him describe him as focused, dedicated, and passionate leader with a mind and proficiency for progress. His leadership style is to value those he works with, and he prides himself on being an excellent listener with an open-door policy.
Lilith Hayakawa Mist is an innovative servant-leader who has dedicated her professional life to excellence in the conduct of clinical trials. She has over 23 years experience delivering complex projects in a wide range of therapeutic areas. Passionate about increasing access to clinical trials, she is leading initiatives to increase clinical trial awareness, deepen community engagement, and maintain monitoring oversight during times of disruption. As Executive Director, Global Clinical Trial Operations, she oversees US ID & Vaccine trial operations for Merck.
Throughout her career, Allie has been focused on technology to propel clinical research and healthcare. As the Director of Strategy for Veeva’s Site Solutions team, she is dedicated to empowering research sites with purpose-built, connected technology that simplifies the complex work of conducting clinical trials.
Prior to her current role, she spent nearly seven years in research operations at the MedStar Health Research Institute, and before that, led implementation and support of EMR and CTMS applications at healthcare and research organizations across the country. Over years of working alongside research teams, Allie is acutely aware of the hurdles that come with adopting new technology. She’s a firm believer that the compounding number of study-specific research applications does not serve research staff or patients – but the right technology can make research run better for all involved. Allie joined Veeva because she is passionate about Veeva’s commitment to a future of fewer systems and happier sites.
Dr. Savanna Mueller is an experienced researcher and educator. She has been with Ripple Science since its launched operations in 2017. She has used her background in clinical research and as an instructor to develop Ripple’s onboarding and training program that has helped over 3,000 studies successfully launch on the Ripple software platform.
Ramy is the founder of 1000 Days Out and author of the AI Product Design Handbook. As the former Managing Director of Design & Strategy for Architech and Head of Innovation for Mattel, he has led the creation of disruptive new digital products & platforms with companies including Apple, Air Canada, New Balance, and Facebook. Ramy teaches post-graduate courses in Design Thinking, Entrepreneurship, and AI Design at several Universities in Canada and around the world.
Dr. Nunez is an internist and Board-Certified Geriatrician who has been a full time Clinical Investigator since 1996. She has conducted over 500 trials and joined Synexus Clinical Research’s NY site in 2018, where she is the Principal Investigator.
Josh O’Rourke, MSc, MBA
Chief Technology Officer
Josh O’Rourke is the Chief Technology Officer at ObjectiveHealth, an integrated research organization dedicated to increasing patient access to innovative treatment options by making clinical trials accessible at the point-of-care. With nearly two decades of experience in Software Engineering, Systems Integration, and Data Science, Josh has spent the last 14 years focusing on healthcare. His expertise and accomplishments span a wide range of areas, including Population Health, Chronic Care Management, Remote Patient Monitoring, Revenue Cycle Management, and Clinical Research. He is a proud graduate of the Georgia Institute of Technology, where he studied artificial intelligence and machine learning.
At ObjectiveHealth, Josh and his team spearhead efforts to accelerate clinical trials with innovative technologies like ObjectiveScreen and ObjectiveView. ObjectiveScreen is a cutting-edge patient recruitment technology that harnesses AI and machine learning to seamlessly match the right patients with the right trials at the point of care. ObjectiveView is a powerful analytics platform that equips clinical trial sponsors with real-time insights into the recruitment funnel. With a deep passion for improving patient care, Josh’s continual focus is using technology to advance the field of clinical research and the healthcare industry as a whole.
Senior Director of Relationships
Stephen has worked in various sales roles within the clinical research space for the past 6 years, including eCOA, EDC, patient recruitment, and has overseen dozens of SMART-on-FHIR EHR-to-EDC integrations. He resides in Sonoma, California with his wife Ellie and dog Oscar.
Chief Commercial Officer
Casey is Chief Commercial Officer for CenExel, the U.S. leader of independent wholly-owned clinical research sites, representing 19 Centers of Excellence specializing in inpatient and outpatient services in a wide range of therapeutic areas including Psychiatry, CNS, Analgesics/Pain, Dermatology and Vaccines.
Casey has a long and exemplary career history in pharmaceutical research services and began his career leading a large pharmaceutical research site network, Research Solutions. He was then recruited to join Clinical Research Advantage/Radiant as EVP of BD and successfully led a network of over 75 research sites conducting clinical trials for pharmaceuticals, vaccines, and medical devices. Under Casey’s leadership, several crucial partnerships were formed with major pharmaceutical companies which fueled the company’s rapid growth both geographically and within the medical community. He facilitated the acquisition of two competitors securing the company’s spot as what was at the time the largest clinical research site network in the US. In 2015, Casey and the executive team at Radiant merged with Synexus, a division of PPD. With Casey’s guidance, Synexus continued to expand to 215 global clinical sites in 4 continents and over 15 countries. Casey also served as President of the Society for Clinical Research Sites from 2019-2021.
Casey is passionate about representing the site voice within the industry while ensuring every research patient’s journey is a positive one. As a thought leader in the industry, Casey is regularly invited to be a keynote speaker and panelist and is often quoted by the leading publications covering the clinical research landscape. In 2020, he was recognized in PharmaVoice as one of the 100 Most Inspiring People in the industry.
Gino Pirri is a seasoned technology executive in the eClinical technology space, with more than 25 years of expertise in driving innovation and leveraging technology to enhance the clinical trial experience. As the head of Product and Technology for Thermo Fisher’s Clinical Research Group (PPD). Gino is spearheading the development of cutting-edge advancements in digital and decentralized trials, with a strong focus on improving the patient and site experience. Gino is driven by his passion for leveraging technology to enhance clinical trial processes and create a more seamless and efficient digital experience for all stakeholders. His professional focus centers around breaking down the barriers of the current fragmented clinical technology space that can often hinder progress and cause unnecessary burden. Prior to joining PPD, Gino held various technology leadership positions where he successfully advanced numerous clinical platforms including eCOA, Wearables, Imaging, EDC, Safety Systems, IRT, and Predictive Data Analytics to support technology advancements.
James Riddle, MCSE, CIP, CPIA, CRQM
VP Research Services & Strategic Consulting
James Riddle is the Vice President Research Services & Strategic Consulting for Advarra where he employs his extensive experiences managing large research operations, technology, and research compliance teams to support our client’s research programs and grow Advarra worldwide.
In addition to leading Advarra’s Biosafety Service, Biostatistical Service, GPStm Service, and strategic consulting teams; Mr. Riddle also serves on the Board of the Northwest Association for Biomedical Research (NWABR); as Chair of the Site Accreditation and Standards Initiative (SASI) Accreditation Council; as member of the CTTI and MRCT Steering Committees; as editorial board member for IRB Advisor; as well as a faculty member, mentor, and regular speaker for Public Responsibility in Medicine and Research (PRIM&R).
Prior to joining Advarra, Mr. Riddle served as a leader of the human subject protection and animal care and use program at the Fred Hutchinson Cancer Research Center, one of the nation’s largest independent cancer research centers. In addition, he has previously served as an AAHRPP site visitor and was the Vice President of Operations and Director of Technology at another large central IRB. His expertise includes multi-national research operations and compliance, implementation of research technology solutions, computer software validation, and management of large IRB, IACUC, and IBC systems.
Mr. Riddle has a bachelor’s degree in accounting with an emphasis in computer science from Western Washington University, College of Business and Economics.
Moretta Randle, MBA
Sr. Digital Health Manager, eCOA Management, Decentralized Solutions, Site and Patients
Moretta Randle is a clinical research professional with over 19 years of experience across the site, vendor, sponsor and CRO settings. She has been focused on technology project management since 2009 and currently serves as a digital health PM and eCOA SME for Syneos Health’s Decentralized Solution team. Her experience from the multiple sectors of the industry allows her to have a comprehensive perspective.
Lucia Rodriguez, MS, BS
Director of Research
Evolve Clinical Research
Lucia has worked in the industry for over 12 years and has been an independent consultant for academic centers and multi-site organizations. Currently, she is in charge of the day-to-day operation of 7 sites in Arizona.
Debra Rogge, BSN, MSA
Director, Site Management and Monitoring
Debra is a registered nurse and hold a Master’s Degree in the Management of Health Care Services. Debra‘s Clinical Research Experience has spanned numerous roles in the past 23 years both in the start-up and maintenance phases of sponsored and investigator sponsored studies. Debra’s current role at AstraZeneca is managing Support Services to include Contract negotiations and budgets, Global Trial Master File, CTMS and Regulatory submission systems and Quality Indicators for the Biopharma, US Site Management and Monitoring organization.
Senior Director of Partnerships
Kylie Scheideler, RN, BSN
Senior Director, Project Strategy
Registered Nurse and Director level professional with 12 years experience in clinical trial site operations, management, feasibility and site start up/activation. In her role as Senior Director of Project Strategy at Javara, she leads a team that is responsible for ensuring the pursuit of right fit trials for their healthcare partners through analysis of patient access data, medical and operational insight and alignment with the unmet medical needs of the patients they serve.
Tarra Shingler, MSHS
Chief Commercial Officer
Over 22 years of diverse experience in business development, clinical operations, drug development, outsourcing across emerging biotech, technology/endpoint solutions and full service CRO. A successful leader skilled in growth, management and mentoring with a focus on the intersection of healthcare and technology by reducing patient and site burden.
Specialties: business development, technology, patient recruitment, patient retention, strategic/value partnerships, financial negotiations, Ph II-IV clinical program operations, CRO and other vendor identification, selection and management, vendor contracting and pricing matrices, enterprise agreements, process improvement, QOL tool development and health outcomes, publication planning, KOL interaction.
Vice President, Research Site Development
– Matt has a proven track record contributing to company growth and expansion with 20 years of leadership and development experience in the clinical research, Software as a Service, and communications industries. His career includes deep experience with technology for the clinical research industry and with research site growth and development. Matt is driven by innovation and creating new approaches to help research sites with efficiency and risk reduction. At Slope, Matt is currently the VP of Research Site Development, where he focuses on helping sites transition to Slope’s free inventory and sample management platform. With a continuous focus on the research site experience, Matt has also had roles at organizations including IBM Watson Health, Devana Solutions, Forte, and ICON’s global site network.
US Innovation Lead
Erin Stackowitz leads US Digital and Non-Digital Innovation within the Clinical Sciences Unit CSU at Sanofi, joining in 2021. Her career began in academia at Columbia University Medical Center in New York City, supporting pediatric neuromuscular gene-therapy trials and mitochondrial mutation biomarker research. Erin holds her Bachelor of Science in Biology and Chemistry, from Gettysburg College and is currently in pursuit of a dual Master’s degree in Public Health and Health Economic Policy from Temple University in Pennsylvania.
Director of Outreach & Engagement
Clinical Research Fastrack
With nearly a decade of experience in educational development, Lauren Stockwell is a passionate and driven clinical research professional. As the Director of Outreach & Engagement at Clinical Research Fastrack, she works tirelessly to connect clinical research companies with the next generation of qualified and intentional professionals. Fastrack is the first training program to offer a bootcampstyle, immersive clinical research curriculum to both aspiring research professionals and organizations who need additional onboarding support. Throughout her career, Lauren has been at the forefront of various bootcamp style training programs where she has successfully led and managed teams. She is committed to pushing the boundaries of traditional education and
seeking innovative ways to enhance the learning experience.
Kristin Surdam, MS, PMP, CCRC
Sr. Director, KOL & Strategy
|Kristin is a Certified Clinical Research Professional with more than 15 years of experience in phase I – IV multi-center clinical trials, at both the site and sponsor/CRO levels. She has experience in various industry roles, types of organizations, and therapeutic areas. Kristin has earned industry certifications as both a Clinical Research Coordinator and a Project Manager, demonstrating her proficiency and commitment to the industry. In addition, Kristin holds a Master of Science in Leadership as well as graduate certificates in both Project Management and Conflict Resolution and Negotiation. Kristin serves as a Key Opinion Leader and Subject Matter Expert at Florence Healthcare, working to drive forward clinical research technology, streamline study operations, and ultimately condense the time to market for new therapies.|
Lora E. Todd
Associate Vice President, Clinical Trial Foundations
Lora is an Associate Vice President at Eli Lilly and Company with over 30 years of drug development experience. Lora is passionate about leveraging technology and data to speed the delivery of medicines to people around the world. At Lilly she is responsible for emerging technology that enables clinical trials to be more convenient and accessible to patients globally. She advances foundational and innovative information management approaches across clinical research delivering real-time access to data and ensures clinical drug supply systems are flexible and reliable.
Viviënne van de Walle, MD, PhD, CPI
Viviënne studied medicine in Maastricht & Oxford. Founder of independent site PT&R. Combines clinical research with consulting. Proud winner of the SPRIA EU award and Christine K. Pierre Impact Award.
Karri Venn, RD, CCRC
Chief Operations Officer
Karri Venn brings over 24 years of clinical research experience working at clinical research sites. Ms. Venn has brought experience, knowledge and drive to many of the positions held at LMC Healthcare since 1999. In 2006, Ms. Venn was promoted to Director, Research of LMC Clinical Research, in 2015 to President, Research of LMC Manna Research and 2021 to COO, President of Centricity Research (formerly LMC Manna, True North, Aventiv and IACT Health). Under her tenure, she has been responsible for the successful openings of 13 LMC Healthcare clinics across Canada, including Canada’s only Diabetes Clinical Research Unit, establishing the largest Canadian non-academic Endocrinology Research program, and the integration of various primary care and specialty clinical research sites to form one of the largest integrated research organizations in North America that include therapeutic expertise in all phases of research inclusive of real world/big data. Centricity Research has more than 40 site locations across 4 provinces and 4 states.
She has led the project management teams for >2000 clinical trials and led the response to >50 Sponsor & Regulatory audits. Centricity Research has received the distinct award as a Centre of Excellence in Diabetes clinical research, PRIME status with IQVIA, a Top 50 Great Places to Work for Canada, and SPRIA winners at SCRS Conference 2017. A founding member and present CEO of hyperCORE International, a leading Super Network of clinical sites of 100 sites, 5 countries and 10 site networks. She has been certified in project management through the Project Management Institute, as well as longstanding certification as a Clinical Research Coordinator and Diabetes Educator.
Today, she is a founding Board member of the Canadian Association of Independent Clinical Research Sites (CAICR), and great supporter of both Society for Clinical Research Sites (SCRS) & Association of Clinical Research Professionals (ACRP).
David Vulcano, LCSW, MBA, CIP, RAC
Vice President, Clinical Research Compliance & Integrity
SCRS Honorary President, HCA Healthcare
David is a well-known thought leader and change agent in the clinical research industry through numerous associations, boards, initiatives, publications, presentations and contributions. A native of New Orleans, he has a Master’s degree in both Social Work and Business Administration and maintains the additional credentials of Certified IRB Professional (CIP), Regulatory Affairs Certification (RAC) and Fellow for the Association of Clinical Research Professionals (FACRP). Among other things he is the a Vice President for Clinical Research Compliance & Integrity for HCA Healthcare, providing research-related compliance and strategy consultation to their portfolio of hospitals, physician practices and healthcare technology companies. He also currently serves as the Honorary President for the Society for Clinical Research Sites (SCRS) and President of the Music City Angels. David and his wife are empty-nesters living south of Nashville, Tennessee where they involve themselves in work, family life as well as other charitable and entrepreneurial opportunities.
Karen van Benschoten
Associate Director, DCT Operations Manager
Karen van Benschoten is a member of Bayer’s DCT Strategy and Implementation Team. This specialized team evolved from an innovation initiative in 2019, to further pursue a better means of patient centricity and exploration of new digital technologies. Since then, Bayer has implemented DCT in multiple global clinical trials, inclusive of hybrid and fully remote designs.
With 25+ years of industry experience, Karen’s operational and management expertise spans site, CRO and sponsor organizations. In addition to DCT, she has been involved in several taskforce initiatives related to Site Relations, Risk Based Monitoring, Change Management, Resourcing and Peer Mentorship.
SVP, Rave Platform Technology
Wayne Walker is Senior Vice President, Product for Rave Platform Technology (including Rave EDC, Rave RTSM, Rave Imaging, Rave Coder, and Rave Safety Gateway) at Medidata. His responsibilities include the strategy, development, and delivery of these products across all Research & Development disciplines. Before joining Medidata, Wayne spent 12 years overseeing Product Management for clinical technology used by Data Management and Biometrics at PRA Health Sciences. This involved oversight of Platform as a Service, Software as a Service, on-premise deployed environments, and in-house developed solutions.
Erinne Wasalski, MSHS, ACRP-CP®, ACRP-PM®
Global Head Regional Site Engagement
A leader in Global Clinical Operations team at Daiichi Sankyo, responsible to develop and implement processes to support a team of Regional Site Engagement Managers located both in the US and in Europe. Her team is responsible for developing regional and sitespecific engagement strategies, assisting with site identification/evaluation, supporting sites with study start-up activities and effectively coordinate activities across multiple Daiichi-Sankyo functions (e.g., Clinical Development, Operations Managers, Medical Science Liaisons) relating to site-specific strategies and interactions. At the same time, ensuring alignment with our CRO partners for enhanced site engagement. 20+ years in pharmaceutical study operations management with experience from pre-clinical safety toxicology, clinical pharmacology, and late stage trial management. Former CRA, CRO project manager and clinical program director with a passion for supporting the site perspective in ensuring successfully executed clinical trials.
Denise Windenburg, MHA
Director, Clinical Research Operations Effectiveness
Minneapolis Heart Institute Foundation
|Denise earned a MHA at the UMN and has over 30 years of experience in clinical research at the site level including academia. She is currently the Director of Research Operations Effectiveness at the Minneapolis Heart Institute Foundation (MHIF).|
Kendal Whitlock, MPH
Head of Digital Optimization, RWE Clinical Trials
Kendal K. Whitlock is the Head of Digital Optimization, RWE Clinical Trials, with Walgreens. This role leverages data assets and partnerships to advance culturally responsive approaches to clinical research. In her role, Ms. Whitlock focuses on digital, educational, and community-based solutions to drive access to clinical trials, enabling opportunities that are flexible and convenient for participants.
Ms. Whitlock brings decades of pharmaceutical industry experience to this role. She is respected thought leader who advocates for digital literacy, health equity, and patient empowerment by applying data-driven methods to customize approaches that address patient/community unmet needs.
Ms. Whitlock holds a Master of Public Health degree in Sociomedical Sciences from Columbia University (New York, NY) and is working toward a doctorate. She earned a BA with honors from Spelman College (Atlanta, GA).
Ms. Whitlock has published in peer-reviewed journals, is a global speaker, Co-Lead of the 3C Decentralized Clinical Trials (DCT) Research Curriculum Initiative for the Decentralized Trials Research Alliance (DTRA), Chair of the Product Development and Clinical Research Sub-committee for the Med Tech Color Collaborative Community, member of the Personalized Medicine Coalition (PMC) Health Equity Task Force, Associate Fellow for the 2022-2023 Precision Medicine: Ethics, Politics, and Culture project (Columbia University), member of the NIH-BMGF Innovation Equity Forum Steering Committee, recently named among one of Diversity Woman Media’s Elite 100 Class of 2023, and is the Inaugural Kerry Murphy Healey (KMH) Center Health Innovation Award Recipient (Babson College).